Loading...

Prestige Consumer Healthcare Inc.

PBHNYSE
Healthcare
Medical - Distribution
$76.88
$0.60(0.79%)

Prestige Consumer Healthcare Inc. (PBH) Stock Overview

Explore Prestige Consumer Healthcare Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.5/100

Key Financials

Market Cap3.8B
P/E Ratio17.76
EPS (TTM)$4.29
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$83.62
1 Month$89.17
3 Months$88.00
1 Year Target$93.87

PBH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Prestige Consumer Healthcare Inc. (PBH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $93.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.76 and a market capitalization of 3.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;